ReviewExpert opinion on therapeutic patents2026
AKR1C3 inhibitors and exploiters for the treatment and therapeutic monitoring of cancer: a patent review (2020-present).
Alfie M Case et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.